[演講活動] OHDSI Taiwan x 醫藥品查驗中心 - 推動健康資料治理與法規科學的對話
2025年4月28日
OHDSI Taiwan x 醫藥品查驗中心 - 推動健康資料治理與法規科學的對話
2025年4月28日，我們受邀至財團法人醫藥品查驗中心（Center for Drug Evaluation, CDE），進行主題為「全球數位健康：創造多元真實世界數據與證據的價值」的專題分享與座談交流。
CDE 為衛生福利部食品藥物管理署（Taiwan Food and Drug Administration, TFDA）與中央健康保險署（National Health Insurance Administration, NHIA）之重要合作單位，長期負責我國健康技術評估（Health Technology Assessment, HTA）等相關法規科學任務。此次分享，我以 OHDSI Taiwan Society 理事長的身份，介紹了 OHDSI 在國際健康資料治理架構、法規科學支持機制與全球協作模式的發展與實踐。
OHDSI 不只是科學研究平台，更是跨界合作的共同語言。我們期盼透過持續與政府機構的對話，深化資料治理觀念、支持法規創新，並共同強化台灣在全球健康政策場域的參與與能見度。
#OHDSTITaiwan #RWD #RWE #資料治理 #法規科學 #HTA #TFDA #CDE
Jason’s Global Digital Health Notes: OHDSI Taiwan x Center for Drug Evaluation – Advancing Health Data Governance and Regulatory Science
On April 28, 2025, we were invited to the Center for Drug Evaluation (CDE) to deliver a keynote presentation and engage in a focused discussion on the topic: "Global Digital Health: Creating Value Through Diverse Real-World Data and Evidence."
The CDE is a key partner of both the Taiwan Food and Drug Administration (TFDA) and the National Health Insurance Administration (NHIA), playing a pivotal role in driving Taiwan’s efforts in Health Technology Assessment (HTA) and regulatory science. In this session, as the President of OHDSI Taiwan Society, I introduced the OHDSI initiative and its global progress in establishing health data governance frameworks, supporting regulatory science, and fostering international collaboration.
OHDSI is not just a scientific research platform—it is a common language for cross-sector collaboration. Through continued dialogue with government agencies, we aim to deepen the understanding of data governance, support regulatory innovation, and enhance Taiwan's visibility and engagement in global health policy development.
#OHDSTITaiwan #RWD #RWE #DataGovernance #RegulatoryScience #HTA #TFDA #CDE #GlobalHealthPolicy #OpenScience
